MENU
+Compare
ABCL
Stock ticker: NASDAQ
AS OF
Apr 24, 02:27 PM (EDT)
Price
$2.57
Change
+$0.04 (+1.58%)
Capitalization
750.93M

ABCL AbCellera Biologics Forecast, Technical & Fundamental Analysis

AbCellera Biologics Inc is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner... Show more

ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ABCL with price predictions
Apr 23, 2025

Momentum Indicator for ABCL turns positive, indicating new upward trend

ABCL saw its Momentum Indicator move above the 0 level on April 11, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ABCL's RSI Indicator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ABCL just turned positive on April 11, 2025. Looking at past instances where ABCL's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

ABCL moved above its 50-day moving average on April 23, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABCL advanced for three days, in of 197 cases, the price rose further within the following month. The odds of a continued upward trend are .

ABCL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for ABCL moved below the 200-day moving average on April 02, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABCL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ABCL entered a downward trend on April 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.717) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (25.907) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ABCL is expected to report earnings to rise 5.58% to -12 cents per share on May 08

AbCellera Biologics ABCL Stock Earnings Reports
Q1'25
Est.
$-0.13
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.02
The last earnings report on February 27 showed earnings per share of -11 cents, beating the estimate of -12 cents. With 2.26M shares outstanding, the current market capitalization sits at 750.93M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2215 Yukon Street
Phone
+1 604 559-9005
Employees
586
Web
https://www.abcellera.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BCVCX27.78N/A
N/A
Sterling Capital Behav Lg Cp Val Eq C
AGOCX11.43N/A
N/A
PGIM Jennison Global Equity Income C
LSITX65.33N/A
N/A
ClearBridge Large Cap Growth IS
DIAYX27.03N/A
N/A
Diamond Hill Long-Short Y
PMICX10.30N/A
N/A
Putnam Multi-Asset Income C

ABCL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+0.79%
CRSP - ABCL
62%
Loosely correlated
-1.76%
NTLA - ABCL
59%
Loosely correlated
-2.65%
ABSI - ABCL
57%
Loosely correlated
-0.47%
BEAM - ABCL
57%
Loosely correlated
+3.87%
RXRX - ABCL
57%
Loosely correlated
-0.89%
More